CG Oncology CGON Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's interest income?
- CG Oncology (CGON) reported interest income of $6.29M in Q1 2026.
- How has CG Oncology's interest income changed year-over-year?
- CG Oncology's interest income decreased by 18.8% year-over-year, from $7.75M to $6.29M.
- What is the long-term trend for CG Oncology's interest income?
- Over 2 years (2023 to 2025), CG Oncology's interest income has grown at a 108.2% compound annual growth rate (CAGR), from $6.9M to $29.93M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.